University of AdelaideAdelaide, South Australia, Australia
Disclosure(s): ILiAD biotechnologies: Grant/Research Support
86 - The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-< 70 years old.
Thursday, October 17, 202411:30 AM – 11:45 AM US PT
596 - Immunogenicity and Safety of BPZE1, an Intranasal Live Attenuated Pertussis Vaccine, Evaluated With and Without Tdap in Healthy Children 6 to 17 Years Old: A Phase 2b, Randomized, Active-Controlled Study
Saturday, October 19, 20242:45 PM – 3:00 PM US PT
